At the 30th Semi-Annual Diagnostic Coverage and Reimbursement Conference, Dr. Ben Horton, MD, MHA, Avalon’s VP and Senior Medical Director, will join Julie Wiedower from Guardant Health for an insightful fireside chat. Their discussion will explore the incorporation of FDA oversight of LDTs into payment frameworks, the impact of state biomarker laws on organizational policy, the ongoing influence of Budget Neutrality on decision-making, and the significance of breakthrough designation for commercial plans. This session will provide valuable perspectives on the evolving diagnostic landscape and its implications for coverage and reimbursement.

To register, please visit Q1 Diagnostics.